REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr. Reddy'S Laboratories Malaysia Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Dr. Reddy'S Laboratories Malaysia Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dr. Reddy'S Laboratories Malaysia Sdn. Bhd. is an enterprise based in Malaysia. Its main office is in Kuala Lumpur. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was established on July 10, 2017. In 2024, the company reported a net sales revenue increase of 44.23%. Over the same period, its total assets grew by 27.79%. In 2024, Dr. Reddy'S Laboratories Malaysia Sdn. Bhd.’s net profit margin decreased by 0.33%.

Headquarters
Unit No. So-29-07 & So-29-08, Menara 1, Strata Office, No. 3, Jalan Bangsar, Kl Eco City
Kuala Lumpur; Federal Territories; Postal Code: 59200

Contact Details: Purchase the Dr. Reddy'S Laboratories Malaysia Sdn. Bhd. report to view the information.

Basic Information
Financial Auditors:
Purchase the Dr. Reddy'S Laboratories Malaysia Sdn. Bhd. report to view the information.
Incorporation Date:
July 10, 2017
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr. Reddy'S Laboratories Malaysia Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
44.23%
Total Operating Revenue
44.23%
Operating Profit
4.04%
EBITDA
4.04%
Net Profit/Loss for the Period
28.37%
Total Assets
27.79%
Total Equity
17.76%
Operating Profit Margin
-1.18%
Net Profit Margin
-0.33%
Return on Equity (ROE)
1.24%
Quick Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?